Fewer men were diagnosed with prostate cancer after doctors stopped recommending routine PSA tests, but now rates are going up again, especially for advanced cancer.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Impact of screening guideline changes on prostate cancer incidence and stage.
A cohort study of 200,000 US men aged 50-75 from 2005 to 2021, tracking PSA testing rates, prostate cancer diagnoses, and disease stage before and after 2012 USPSTF recommendations.
Current prostate cancer incidence trends and stage distribution.
A cross-sectional analysis of US prostate cancer incidence data from 2007-2021, examining annual rates and proportion of advanced-stage cases.
Effect of PSA screening on prostate cancer incidence and mortality.
An RCT randomizing 50,000 men to annual PSA screening vs. no screening for 10 years, with follow-up for prostate cancer incidence, stage at diagnosis, and mortality.